ML-SI3 is a selective small-molecule inhibitor of TRPML1, TRPML2, and TRPML3 calcium channels. It serves as a valuable research tool for investigating the role of these channels in lysosomal function, with applications in studies of neurodegenerative and cardiovascular disease models both in vitro and in vivo.